Research News
Researchers at the George Washington University (GW) have developed a way to test recombinant vaccines for their ability to stay effective after years of storage. This is an important next step in the development of a recombinant hookworm vaccine being developed at GW.
Mandi Pratt-Chapman, M.A., associate center director for patient-centered initiatives and health equity at the GW Cancer Center, co-authored a commentary published in The Lancet Oncology, which calls to bridge the gap between the achievable and the accessible in cancer care.
Lisa M. Guay-Woodford, M.D., director of the Clinical and Translational Science Institute at Children’s National (CTSI-CN) and Hudson Professor of Pediatrics and Associate Vice President for Clinical and Translational Science, and Robert H. Miller, Ph.D., co-director of the CTSI-CN and…
Chiara Manzini, Ph.D., assistant professor in pharmacology & physiology, published research in the American Journal of Human Genetics about a newly discovered mutation in the INPP5K gene, which leads to short stature, muscle weakness, intellectual disability, and cataracts, and…
A large international survey, published in the Journal of the European Academy of Dermatology & Venereology by researchers from La Roche-Posay and GW, asked nearly 20,000 participants about their sun protection behavior and skin cancer awareness.
The Rheumatology Research Foundation recently awarded Aileen Y. Chang, M.D., M.S.P.H., a $75,000 pilot grant to fund her research in rheumatology for a project entitled, “A Pilot Study of the Pathogenesis of Chikungunya Arthritis in the Americas.”
Jeffrey M. Bethony, Ph.D., professor, and David Diemert, M.D., associate professor, both in the Department of Microbiology, Immunology, and Tropical Medicine, served as co-authors on a review on hookworm infection published in Nature Reviews: Disease Primers.
Patricia Berg, Ph.D., professor of biochemistry and molecular medicine, has been named a Fellow of the American Association for the Advancement of Science.
Matthew Colonnese, Ph.D., assistant professor of pharmacology and physiology, published a paper in the Journal of Neuroscience establishing a mouse model for human fetal electrographic development.
Narine Sarvazyan, Ph.D., professor of pharmacology and physiology, parntered with Noctural Product Development to receive a $2.27 million Phase II STTR grant to support ongoing efforts to design, produce, and test real-time lesion visualization tools for cardiac ablation procedures.